CV6 Therapeutics
Business Services · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
97 Lisburn Rd, Belfast, BT9 7AE, United ...Phone Number
+44 2890972674Website
www.cv6t.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About CV6 Therapeutics
CV6 Therapeutics is an early-stage biotech company based in Belfast, Northern Ireland, focused on developing innovative therapies for oncology and inflammatory diseases. The company aims to disrupt traditional therapies by creating novel, first-in-class small molecules that address significant unmet medical needs. Their mission is to transform patient care through cutting-edge science and effective mechanisms of action. CV6 Therapeutics is currently advancing its clinical pipeline, including the CV6-168 Phase 1a clinical trial.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CV6 Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if CV6 Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at CV6 Therapeutics
CV6 Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on CV6 Therapeutics recently announced quarterly report
Product Launch: Get notified when CV6 Therapeutics launches new products
Funding: Get notified immidiatlly once CV6 Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if CV6 Therapeutics is spiking on competitors!
Check if CV6 Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at CV6 Therapeutics
Find 3 more new buyers
Compare Similar Companies to CV6 Therapeutics
Compare insights from companies similar to CV6 Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CV6 Therapeutics
<$5M
1-10
Private
$9.2M
2013
N/A
Company Profile Activity
Activity Insights
CV6 Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CV6 Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CV6 Therapeutics.
CV6 Therapeutics financials insights
Gather financial insights about CV6 Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$9.2M
CV6 Therapeutics Tech Stack
A closer look at the technologies used by CV6 Therapeutics
See more technologies
CV6 Therapeutics News & Media
CV6 Therapeutics Announces Initiation of Patient Dosing in Phase 1a Clinical Trial Evaluating the Investigational First-In-Class, Specific dUTPase Inhibitor CV6-168
– Study will assess the safety, pharmacokinetic and pharmacodynamic profiles and anti-tumor activity for CV6-168 in the treatment of multiple solid cancers, including colon, gastric, breast, ovarian, lung, and other solid tumorsCV6 Therapeutics Secures $9.2m to Progress Novel Cancer Drug to Phase 1a Trial
CV6 Therapeutics Secures $9.2m to Progress Novel Cancer Drug to Phase 1a Trial
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding CV6 Therapeutics
Sign Up For FreeTo access detailed company insights
CV6 Therapeutics is an early-stage biotech company based in Belfast, Northern Ireland, focused on developing innovative therapies for oncology and inflammatory diseases. The company aims to disrupt traditional therapies by creating novel, first-in-class small molecules that address significant unmet medical needs. Their mission is to transform pati... Read More
